[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1199062A1 - Cell free translation system for compound screening and related uses - Google Patents

Cell free translation system for compound screening and related uses

Info

Publication number
HK1199062A1
HK1199062A1 HK14112552.9A HK14112552A HK1199062A1 HK 1199062 A1 HK1199062 A1 HK 1199062A1 HK 14112552 A HK14112552 A HK 14112552A HK 1199062 A1 HK1199062 A1 HK 1199062A1
Authority
HK
Hong Kong
Prior art keywords
translation system
cell free
free translation
compound screening
related uses
Prior art date
Application number
HK14112552.9A
Other languages
Chinese (zh)
Inventor
．林佳帕
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1199062A1 publication Critical patent/HK1199062A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36151—Methods of production or purification of viral material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/065—Poxviridae, e.g. avipoxvirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK14112552.9A 2011-08-03 2014-12-11 Cell free translation system for compound screening and related uses HK1199062A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161514825P 2011-08-03 2011-08-03
PCT/US2012/049625 WO2013020101A2 (en) 2011-08-03 2012-08-03 Cell free translation system for compound screening and related uses

Publications (1)

Publication Number Publication Date
HK1199062A1 true HK1199062A1 (en) 2015-06-19

Family

ID=47629941

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112552.9A HK1199062A1 (en) 2011-08-03 2014-12-11 Cell free translation system for compound screening and related uses

Country Status (11)

Country Link
US (4) US20120301904A1 (en)
EP (1) EP2739730B1 (en)
JP (2) JP2014524244A (en)
KR (1) KR20140074885A (en)
CN (1) CN103917645B (en)
AU (2) AU2012289869A1 (en)
CA (1) CA2843905C (en)
HK (1) HK1199062A1 (en)
IL (1) IL230767A0 (en)
SG (1) SG10201606327WA (en)
WO (1) WO2013020101A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
US20140106365A1 (en) * 2012-07-24 2014-04-17 Prosetta Antiviral, Inc. Multiprotein assemblies
EP3077551B1 (en) 2013-12-06 2020-04-01 President and Fellows of Harvard College Paper-based synthetic gene networks

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2083488A (en) 1980-08-28 1982-03-24 Shell Int Research Light-sensitive dyestuffs
US4604458A (en) 1984-07-31 1986-08-05 The Hilton-Davis Chemical Co. 3-substituted carbonyloxy-7-disubstituted amino-10-substituted carbonylphenothiazines
US5506337A (en) 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
AU638762B2 (en) * 1989-10-05 1993-07-08 Optein Inc Cell-free synthesis and isolation of novel genes and polypeptides
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5843641A (en) 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
US5519134A (en) 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5593853A (en) 1994-02-09 1997-01-14 Martek Corporation Generation and screening of synthetic drug libraries
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5549974A (en) 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
US5569588A (en) 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
DE19640758C2 (en) 1996-10-02 1999-11-04 Rafael Lachky Means for the treatment of discus fish
US7638269B2 (en) 1997-02-07 2009-12-29 The Regents Of The University Of California Viral capsid assembly intermediates and methods of production
US20030104577A1 (en) * 1997-02-07 2003-06-05 Uc Regents HIV capsid assembly-associated compositions and method
US6593103B1 (en) * 1997-02-07 2003-07-15 The Regents Of The University Of California HIV capsid assembly-associated compositions and method
EP0861900A1 (en) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
KR100546009B1 (en) 1999-05-11 2006-01-25 셀프리 사이언스 코 엘티디 Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing cell-free protein
CA2394609C (en) 1999-12-15 2007-03-13 The Regents Of The University Of California Conformational and topological protein regulation
FR2810318B1 (en) 2000-06-15 2005-09-23 Laurent Galey DIAMANO-PHENOTHIAZINE DERIVATIVES
EP1310564A4 (en) 2000-07-21 2004-08-04 Nat Inst Of Advanced Ind Scien General means of labeling protein by using wheat embryo cell-free protein synthesis system
JP4267621B2 (en) * 2000-08-29 2009-05-27 株式会社セルフリーサイエンス Cell-free protein synthesis method
DE60129717D1 (en) * 2000-08-29 2007-09-13 Cellfree Sciences Co Ltd PROCESS FOR SYNTHESIS OF CELL-FREE PROTEINS
KR20030031993A (en) * 2000-08-30 2003-04-23 야에타 엔도 Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same
JP2002125693A (en) 2000-10-19 2002-05-08 Toyobo Co Ltd Cell extract composition for synthesizing cell-free protein
US7067550B2 (en) 2000-11-03 2006-06-27 Massachusetts Institute Of Technology Treatments for neurotoxicity in Alzheimer's Disease
GB0113121D0 (en) 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
US20030022243A1 (en) 2001-06-20 2003-01-30 Les Kondejewski Protein aggregation assays and uses thereof
CA2483332A1 (en) 2002-01-31 2003-08-07 Yaeta Endo Cell extract for cell-free protein synthesis and process for producing the same
US7273615B2 (en) 2002-02-28 2007-09-25 Cellfree Sciences Co., Ltd. Reaction solution for cell-free protein synthesis, method of preparing the same, and protein synthesis method using the same
EP1537205A2 (en) * 2002-09-13 2005-06-08 The Regents of the University of California Viral deconstruction through capsid assembly in vitro
CA2502281A1 (en) 2002-10-10 2004-04-22 Regents Of The University Of California Use of monoclonal antibodies to distinguish protein conformational isoforms
CN1777674B (en) * 2003-04-25 2012-05-23 株式会社无细胞科学 High-flux protein synthesis system and synthesis device for automatically operating same
JP2006042601A (en) * 2003-04-25 2006-02-16 Yaeta Endo High throughput synthetic system
US20070003977A1 (en) 2003-08-20 2007-01-04 Amorfix Life Sciences Ltd Epitope protection assay and method for detecting protein conformations
WO2005024428A1 (en) * 2003-09-08 2005-03-17 Cellfree Sciences Co., Ltd. Novel high throughput screening method of drug for physiologically active protein
JP2007512297A (en) 2003-11-28 2007-05-17 フォトファーマイカ リミテッド Development in bioactive methylene blue derivative (2)
EP1800125A4 (en) 2004-09-16 2009-04-29 Univ Case Western Reserve Detection of protein aggregates by homologous elisa
WO2006034219A2 (en) 2004-09-17 2006-03-30 The General Hospital Corporation Inactivation of microorganisms with multidrug resistance inhibitors and phenothiaziniums
GB0420888D0 (en) 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
GB0420893D0 (en) 2004-09-20 2004-10-20 Photopharmica Ltd Photosensitisers and their uses
EP2322517B1 (en) 2004-09-23 2019-04-24 WisTa Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
US20060264423A1 (en) 2005-05-20 2006-11-23 Bioenvision, Inc. Methylene Blue Therapy of Viral Disease
WO2007044894A2 (en) * 2005-10-11 2007-04-19 Chembridge Research Laboratories, Inc. Cell-free protein expression systems and methods of use thereof
JP2007199047A (en) 2005-12-28 2007-08-09 Cellfree Sciences Co Ltd Method for preparing biotinylated protein, and detecting method using the protein
EP2137172A1 (en) 2007-04-03 2009-12-30 Prosetta Bioconformatics Inc. Phenothiazin derivatives for antiviral treatments
US20100310461A1 (en) 2007-04-18 2010-12-09 Biochromix Pharma Ab Binding of pathological forms of proteins using conjugated polyelectrolytes
FR2920775B1 (en) 2007-09-07 2009-11-06 Pharma Hydro Dev P H D Soc Par NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, PROCESS FOR PREPARING THEM AND USES THEREOF.
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
JO3421B1 (en) 2011-06-20 2019-10-20 H Lundbeck As Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia

Also Published As

Publication number Publication date
EP2739730B1 (en) 2019-05-15
US20150226748A1 (en) 2015-08-13
CA2843905C (en) 2021-09-07
JP2017018136A (en) 2017-01-26
IL230767A0 (en) 2014-03-31
AU2017254796A1 (en) 2017-11-16
CN103917645A (en) 2014-07-09
KR20140074885A (en) 2014-06-18
AU2012289869A1 (en) 2014-02-20
WO2013020101A2 (en) 2013-02-07
WO2013020101A8 (en) 2013-08-29
EP2739730A4 (en) 2015-03-11
EP2739730A2 (en) 2014-06-11
US20170159097A1 (en) 2017-06-08
WO2013020101A3 (en) 2013-04-18
US20120301904A1 (en) 2012-11-29
CA2843905A1 (en) 2013-02-07
SG10201606327WA (en) 2016-09-29
US10036755B2 (en) 2018-07-31
US20130053267A1 (en) 2013-02-28
JP2014524244A (en) 2014-09-22
CN103917645B (en) 2020-05-01

Similar Documents

Publication Publication Date Title
PL2559246T3 (en) Sample region merging
HK1183085A1 (en) Frame member for structure
GB2496040B (en) Predicted fault analysis
EP2577260A4 (en) Inspection system
EP2637015A4 (en) Cell analyzer
EP2609733A4 (en) Techniques for object based operations
ZA201300621B (en) T cell receptors
EP2779298A4 (en) Solid electrolyte
HK1180345A1 (en) Methods for screening antibodies
EP2698839A4 (en) Cell block
TWI561141B (en) Sealing structure
GB201017421D0 (en) Cell
EP2725341A4 (en) Cell analyzer
EP2677593A4 (en) Cell case, and structure for attaching cell case
HK1181698A1 (en) Sample plate
EP2800229A4 (en) Cell system
EP2709203A4 (en) Cell system
GB201303197D0 (en) Frame structure for stage errection
PL2380747T3 (en) Method for providing panels
HK1199062A1 (en) Cell free translation system for compound screening and related uses
PL2643088T3 (en) Closure assembly for cell culture apparatus
AP3498A (en) Biogas system
GB201112068D0 (en) Cell development system
AP4013A (en) Biogas system
GB201019108D0 (en) Cell